Clostridioides difficile MreE (PBP2) variants facilitate clinical disease during cephalosporin exposures
View ORCID ProfileJay Noboru Worley, View ORCID ProfileNicholas D. Benedetto, View ORCID ProfileMary Delaney, View ORCID ProfileAna Oliveira Paiva, View ORCID ProfileMarie-Pierre Chapot-Chartier, View ORCID ProfileJohann Peltier, View ORCID ProfileLynn Bry
doi: https://doi.org/10.1101/2023.10.23.23297415
Jay Noboru Worley
1Massachusetts Host-Microbiome Center, Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA
2National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, Maryland, USA
Nicholas D. Benedetto
1Massachusetts Host-Microbiome Center, Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA
Mary Delaney
1Massachusetts Host-Microbiome Center, Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA
3Clinical Microbiology Laboratory, Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA
Ana Oliveira Paiva
4Institute for Integrative Biology of the Cell, University of Paris-Saclay, Alternative Energies and Atomic Energy Commission, National Centre for Scientific Research, Gif-sur-Yvette, France
Marie-Pierre Chapot-Chartier
5AgroParisTech, Micalis Institute, University of Paris-Saclay, National Research Institute for Agriculture, Food and Environment, Jouy-en-Josas, Franc
Johann Peltier
4Institute for Integrative Biology of the Cell, University of Paris-Saclay, Alternative Energies and Atomic Energy Commission, National Centre for Scientific Research, Gif-sur-Yvette, France
Lynn Bry
1Massachusetts Host-Microbiome Center, Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA
3Clinical Microbiology Laboratory, Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA
Article usage
Posted October 24, 2023.
Clostridioides difficile MreE (PBP2) variants facilitate clinical disease during cephalosporin exposures
Jay Noboru Worley, Nicholas D. Benedetto, Mary Delaney, Ana Oliveira Paiva, Marie-Pierre Chapot-Chartier, Johann Peltier, Lynn Bry
medRxiv 2023.10.23.23297415; doi: https://doi.org/10.1101/2023.10.23.23297415
Clostridioides difficile MreE (PBP2) variants facilitate clinical disease during cephalosporin exposures
Jay Noboru Worley, Nicholas D. Benedetto, Mary Delaney, Ana Oliveira Paiva, Marie-Pierre Chapot-Chartier, Johann Peltier, Lynn Bry
medRxiv 2023.10.23.23297415; doi: https://doi.org/10.1101/2023.10.23.23297415
Subject Area
Subject Areas
- Addiction Medicine (390)
- Allergy and Immunology (705)
- Anesthesia (196)
- Cardiovascular Medicine (2877)
- Dermatology (245)
- Emergency Medicine (432)
- Epidemiology (12604)
- Forensic Medicine (10)
- Gastroenterology (811)
- Genetic and Genomic Medicine (4476)
- Geriatric Medicine (407)
- Health Economics (717)
- Health Informatics (2867)
- Health Policy (1057)
- Hematology (378)
- HIV/AIDS (907)
- Medical Education (418)
- Medical Ethics (115)
- Nephrology (465)
- Neurology (4233)
- Nursing (226)
- Nutrition (620)
- Oncology (2218)
- Ophthalmology (631)
- Orthopedics (255)
- Otolaryngology (322)
- Pain Medicine (270)
- Palliative Medicine (83)
- Pathology (489)
- Pediatrics (1182)
- Primary Care Research (485)
- Public and Global Health (6818)
- Radiology and Imaging (1502)
- Respiratory Medicine (907)
- Rheumatology (430)
- Sports Medicine (373)
- Surgery (475)
- Toxicology (59)
- Transplantation (204)
- Urology (175)